Sol Gel Technologies Ltd
NASDAQ:SLGL

Watchlist Manager
Sol Gel Technologies Ltd Logo
Sol Gel Technologies Ltd
NASDAQ:SLGL
Watchlist
Price: 44.19 USD 4.84% Market Closed
Market Cap: 123.1m USD

During the last 3 months Sol Gel Technologies Ltd insiders bought 3.5m USD , and have not sold any shares. The stock price has increased by 3% over this period (open performance analysis).

The last transaction was made on Dec 31, 2025 by Opaleye Management Inc. , who bought 944.7k USD worth of SLGL shares.

Last Transactions:
Opaleye Management Inc.
$+944.7k
Opaleye Management Inc.
Director
$+1.5m
Opaleye Management Inc.
Director
$+361.5k
Opaleye Management Inc.
$+67.8k
Opaleye Management Inc.
Director
$+10.8k
Opaleye Management Inc.
Director
$+41.9k
Opaleye Management Inc.
$+110.4k
Opaleye Management Inc.
$+3.5k
Opaleye Management Inc.
$+11.9k
Opaleye Management Inc.
Director
$+17.5k
Opaleye Management Inc.
$+95.4k
Opaleye Management Inc.
Director
$+162.2k
Opaleye Management Inc.
$+37.7k
Opaleye Management Inc.
Director
$+213
Opaleye Management Inc.
$+207.2k
View All Transactions

During the last 3 months Sol Gel Technologies Ltd insiders bought 3.5m USD , and have not sold any shares. The stock price has increased by 3% over this period (open performance analysis).

The last transaction was made on Dec 31, 2025 by Opaleye Management Inc. , who bought 944.7k USD worth of SLGL shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
1
3.5m USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Sol Gel Technologies Ltd
Insider Trading Chart

Sol Gel Technologies Ltd
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Sol Gel Technologies Ltd
Last Insider Transactions

Global
Insiders Monitor

Sol Gel Technologies Ltd
Glance View

Market Cap
123.1m USD
Industry
Pharmaceuticals

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

SLGL Intrinsic Value
13.87 USD
Overvaluation 69%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top